Teva Pharmaceutical Industries Limited
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2009
Total Assets: $33.21B
Liabilities Breakdown FY2009
Total Liabilities: $13.95B
Asset Breakdown
Total Assets: $33.21B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $2.00B | 6.0% |
| Accounts Receivable | $5.02B | 15.1% |
| Inventory | $3.33B | 10.0% |
| Property, Plant & Equipment | $3.77B | 11.3% |
| Goodwill | $12.67B | 38.2% |
| Intangible Assets | $4.05B | 12.2% |
| Other Assets | $2.37B | 7.1% |
Liabilities Breakdown
Total Liabilities: $13.95B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.35B | 16.8% |
| Long-Term Debt | $4.06B | 29.1% |
| Other Liabilities | $7.54B | 54.1% |